Latest Breaking News On - Intas pharmaceuticals on - Page 1 : comparemela.com

mAbxience, a majority-owned company of German drug maker Fresenius Kabi, also has partial ownership from Insud Pharma, will be responsible for the development, manufacturing, and supply of the Etanercept biosimilar.

Insud pharmaFresenius kabiSamsung bioepisBinish chudgarIntas pharmaceuticals onIntas pharmaceuticalsSpanish drug makerBiosimilar etanercept